Photo from wikipedia
Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD). Better understanding of molecular pathways leading to DMD fibrosis may provide novel targets for drug therapy. Matrix metalloproteinases… Click to show full abstract
Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD). Better understanding of molecular pathways leading to DMD fibrosis may provide novel targets for drug therapy. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate collagen
Keywords:
muscular dystrophy;
tissue inhibitors;
inhibitors metalloproteinases;
duchenne muscular;
matrix metalloproteinases
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!